Theodore R. Schroeder

Insider Reports History

Location
San Diego, CA
Signature
/s/ Shane Ward, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Theodore R. Schroeder:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Phathom Pharmaceuticals, Inc. Director Common Stock 21K $95.6K $4.55 16 Apr 2025 Direct
Nabriva Therapeutics plc Director Ordinary Shares 12K $18K $1.50 29 Jan 2023 Direct
Nabriva Therapeutics plc Director Stock Appreciation Right 240K 11 Aug 2022 Direct
Nabriva Therapeutics plc Director Phantom Shares 120K 11 Aug 2022 Direct
Phathom Pharmaceuticals, Inc. Director Common Stock (Right to Buy) 35K 16 Apr 2025 Direct
OTONOMY, INC. Director Stock Option (right to buy) 27.5K 21 Jun 2022 Direct
Cidara Therapeutics, Inc. Director Stock Option (right to buy) 11.1K 18 Jun 2025 Direct
Nabriva Therapeutics plc Director Restricted Stock Units 0 11 Aug 2022 Direct
Nabriva Therapeutics plc Director Share Options 0 11 Aug 2022 Direct
Phathom Pharmaceuticals, Inc. Director No securities are beneficially owned. 0 16 Apr 2025 Direct

Insider Reports Filed by Theodore R. Schroeder

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CDTX Cidara Therapeutics, Inc. 18 Jun 2025 1 $0 4 18 Jun 2025 Director
PHAT Phathom Pharmaceuticals, Inc. 16 Apr 2025 2 $0 4 16 Apr 2025 Director
PHAT Phathom Pharmaceuticals, Inc. 16 Apr 2025 0 $0 3 16 Apr 2025 Director
CDTX Cidara Therapeutics, Inc. 17 Dec 2024 1 $0 4 19 Dec 2024 Director
CDTX Cidara Therapeutics, Inc. 18 Jul 2024 1 $0 4 19 Jul 2024 Director
CDTX Cidara Therapeutics, Inc. 22 Jun 2023 1 $0 4 23 Jun 2023 Director
NBRVF Nabriva Therapeutics plc 29 Jan 2023 1 -$647 4 31 Jan 2023 Director
NBRVF Nabriva Therapeutics plc 06 Jan 2023 1 -$14 4 10 Jan 2023 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 31 Dec 2022 1 -$9 4 04 Jan 2023 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 06 Dec 2022 1 -$18 4 08 Dec 2022 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 30 Nov 2022 1 -$11 4 02 Dec 2022 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 06 Nov 2022 1 -$22 4 08 Nov 2022 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 31 Oct 2022 1 -$13 4 01 Nov 2022 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 06 Oct 2022 1 -$25 4 11 Oct 2022 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 30 Sep 2022 1 -$10 4 04 Oct 2022 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 06 Sep 2022 1 -$35 4 07 Sep 2022 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 31 Aug 2022 1 -$18 4 01 Sep 2022 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 11 Aug 2022 4 $0 4 15 Aug 2022 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 06 Aug 2022 1 -$42 4 08 Aug 2022 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 31 Jul 2022 1 -$19 4 03 Aug 2022 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 06 Jul 2022 1 -$41 4 07 Jul 2022 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 30 Jun 2022 1 -$20 4 01 Jul 2022 Chief Executive Officer, Director
CDTX Cidara Therapeutics, Inc. 22 Jun 2022 1 $0 4 24 Jun 2022 Director
OTIC OTONOMY, INC. 21 Jun 2022 1 $0 4 23 Jun 2022 Director
NBRVF Nabriva Therapeutics plc 06 Jun 2022 1 -$45 4 07 Jun 2022 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 31 May 2022 1 -$22 4 02 Jun 2022 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 06 May 2022 1 -$59 4 09 May 2022 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 30 Apr 2022 1 -$33 4 03 May 2022 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 06 Apr 2022 1 -$90 4 08 Apr 2022 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 31 Mar 2022 1 -$44 4 04 Apr 2022 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 06 Mar 2022 1 -$113 4 08 Mar 2022 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 28 Feb 2022 1 -$56 4 02 Mar 2022 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 06 Feb 2022 1 -$126 4 08 Feb 2022 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 29 Jan 2022 2 -$4.9K 4 01 Feb 2022 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 28 Jan 2022 2 $0 4 01 Feb 2022 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 06 Jan 2022 1 -$157 4 10 Jan 2022 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 31 Dec 2021 1 -$64 4 04 Jan 2022 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 28 Dec 2021 1 $57.3K 4 29 Dec 2021 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 06 Dec 2021 1 -$162 4 08 Dec 2021 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 30 Nov 2021 1 -$84 4 02 Dec 2021 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 06 Nov 2021 1 -$299 4 09 Nov 2021 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 31 Oct 2021 1 -$123 4 01 Nov 2021 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 06 Oct 2021 1 -$243 4 08 Oct 2021 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 30 Sep 2021 1 -$127 4 04 Oct 2021 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 14 Sep 2021 1 $56.5K 4 15 Sep 2021 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 06 Sep 2021 1 -$250 4 08 Sep 2021 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 31 Aug 2021 1 -$113 4 02 Sep 2021 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 06 Aug 2021 1 -$263 4 10 Aug 2021 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 31 Jul 2021 1 -$118 4 03 Aug 2021 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 06 Jul 2021 1 -$286 4 08 Jul 2021 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 30 Jun 2021 1 -$144 4 02 Jul 2021 Chief Executive Officer, Director
CDTX Cidara Therapeutics, Inc. 23 Jun 2021 1 $0 4 24 Jun 2021 Director
OTIC OTONOMY, INC. 22 Jun 2021 1 $0 4 24 Jun 2021 Director
NBRVF Nabriva Therapeutics plc 06 Jun 2021 1 -$302 4 08 Jun 2021 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 31 May 2021 1 -$148 4 02 Jun 2021 Chief Executive Officer, Director
NBRVF Nabriva Therapeutics plc 06 May 2021 1 -$335 4 10 May 2021 Chief Executive Officer, Director